Literature DB >> 22182677

"Electro-clinical syndromes" with onset in paediatric age: the highlights of the clinical-EEG, genetic and therapeutic advances.

Pasquale Parisi1, Alberto Verrotti, Maria Chiara Paolino, Rosa Castaldo, Filomena Ianniello, Alessandro Ferretti, Francesco Chiarelli, Maria Pia Villa.   

Abstract

The genetic causes underlying epilepsy remain largely unknown, and the impact of available genetic data on the nosology of epilepsy is still limited. Thus, at present, classification of epileptic disorders should be mainly based on electroclinical features. Electro-clinical syndrome is a term used to identify a group of clinical entities showing a cluster of electro-clinical characteristics, with signs and symptoms that together define a distinctive, recognizable, clinical disorder. These often become the focus of treatment trials as well as of genetic, neuropsychological, and neuroimaging investigations. They are distinctive disorders identifiable on the basis of a typical age onset, specific EEG characteristics, seizure types, and often other features which, when taken together, permit a specific diagnosis which, in turn, often has implications for treatment, management, and prognosis. Each electro-clinical syndrome can be classified according to age at onset, cognitive and developmental antecedents and consequences, motor and sensory examinations, EEG features, provoking or triggering factors, and patterns of seizure occurrence with respect to sleep. Therefore, according to the age at onset, here we review the more frequently observed paediatric electro-clinical syndrome from their clinical-EEG, genetic and therapeutic point of views.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22182677      PMCID: PMC3267655          DOI: 10.1186/1824-7288-37-58

Source DB:  PubMed          Journal:  Ital J Pediatr        ISSN: 1720-8424            Impact factor:   2.638


  127 in total

1.  Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy.

Authors:  Petter Strømme; Marie E Mangelsdorf; Marie A Shaw; Karen M Lower; Suzanne M E Lewis; Helene Bruyere; Viggo Lütcherath; Agi K Gedeon; Robyn H Wallace; Ingrid E Scheffer; Gillian Turner; Michael Partington; Suzanna G M Frints; Jean-Pierre Fryns; Grant R Sutherland; John C Mulley; Jozef Gécz
Journal:  Nat Genet       Date:  2002-03-11       Impact factor: 38.330

2.  Impact of early hemispherotomy in a case of Ohtahara syndrome with left parieto-occipital megalencephaly.

Authors:  Ghassan Hmaimess; Christian Raftopoulos; Hazim Kadhim; Marie-Cecile Nassogne; Sophie Ghariani; Marianne de Tourtchaninoff; Kenou van Rijckevorsel
Journal:  Seizure       Date:  2005-09       Impact factor: 3.184

Review 3.  Ohtahara syndrome: with special reference to its developmental aspects for differentiating from early myoclonic encephalopathy.

Authors:  Shunsuke Ohtahara; Yasuko Yamatogi
Journal:  Epilepsy Res       Date:  2006-07-10       Impact factor: 3.045

4.  A new type of epilepsy: benign partial epilepsy of childhood with occipital spike-waves.

Authors:  H Gastaut
Journal:  Clin Electroencephalogr       Date:  1982-01

5.  Ictal video-polysomnography and EEG spectral analysis in a child with severe Panayiotopoulos syndrome.

Authors:  Pasquale Parisi; Raffaele Ferri; Jacopo Pagani; Manuela Cecili; Enza Montemitro; Maria Pia Villa
Journal:  Epileptic Disord       Date:  2005-12       Impact factor: 1.819

6.  Levetiracetam monotherapy in newly diagnosed cryptogenic West syndrome.

Authors:  Hakan Gümüş; Sefer Kumandaş; Hüseyin Per
Journal:  Pediatr Neurol       Date:  2007-11       Impact factor: 3.372

7.  Paradoxical precipitation of tonic seizures by lorazepam in a child with atypical absence seizures.

Authors:  F J DiMario; R R Clancy
Journal:  Pediatr Neurol       Date:  1988 Jul-Aug       Impact factor: 3.372

8.  Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures.

Authors:  Tateki Fujiwara; Takashi Sugawara; Emi Mazaki-Miyazaki; Yukitoshi Takahashi; Katsuyuki Fukushima; Masako Watanabe; Keita Hara; Tateki Morikawa; Kazuichi Yagi; Kazuhiro Yamakawa; Yushi Inoue
Journal:  Brain       Date:  2003-03       Impact factor: 13.501

Review 9.  Autonomic status epilepticus in Panayiotopoulos syndrome and other childhood and adult epilepsies: a consensus view.

Authors:  Colin D Ferrie; Roberto Caraballo; Athanasios Covanis; Veysi Demirbilek; Aysin Dervent; Natalio Fejerman; Lucia Fusco; Richard A Grünewald; Osamu Kanazawa; Michael Koutroumanidis; Christina Lada; John H Livingston; Alessia Nicotra; Hirokazu Oguni; Zarko Martinovic; Douglas R Nordli; Pasquale Parisi; Rod C Scott; Nicola Specchio; Alberto Verrotti; Federico Vigevano; Matthew C Walker; Kazuyoshi Watanabe; Harumi Yoshinaga; Chrysostomos P Panayiotopoulos
Journal:  Epilepsia       Date:  2007-04-18       Impact factor: 5.864

10.  The spectrum of SCN1A-related infantile epileptic encephalopathies.

Authors:  Louise A Harkin; Jacinta M McMahon; Xenia Iona; Leanne Dibbens; James T Pelekanos; Sameer M Zuberi; Lynette G Sadleir; Eva Andermann; Deepak Gill; Kevin Farrell; Mary Connolly; Thorsten Stanley; Michael Harbord; Frederick Andermann; Jing Wang; Sat Dev Batish; Jeffrey G Jones; William K Seltzer; Alison Gardner; Grant Sutherland; Samuel F Berkovic; John C Mulley; Ingrid E Scheffer
Journal:  Brain       Date:  2007-03       Impact factor: 13.501

View more
  3 in total

Review 1.  Computational modeling of epilepsy for an experimental neurologist.

Authors:  Abbey B Holt; Theoden I Netoff
Journal:  Exp Neurol       Date:  2012-05-14       Impact factor: 5.330

2.  Risk Factors for Drug Resistance in Epileptic Children with Age of Onset above Five Years: A Case-Control Study.

Authors:  Irawan Mangunatmadja; Raden Muhammad Indra; Dwi Putro Widodo; Achmad Rafli
Journal:  Behav Neurol       Date:  2021-11-10       Impact factor: 3.342

3.  A Temporospatial Study of Sympathetic Skin Response and Electroencephalogram in Oral Mucosa Thermal Perception.

Authors:  Hao Zhang; Shengjing Hu; Zhangang Wang; Xiang Li; Suogang Wang; Gang Chen
Journal:  Front Neurosci       Date:  2022-07-15       Impact factor: 5.152

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.